Sign up Australia
Proactive Investors - Run By Investors For Investors

Tekcapital portfolio stalwart Belluscura raises US$1.6mln

A medical equipment specialist, Belluscura had intended to float on AIM last year
Belluscura specialises in medical equipment

Tekcapital PLC's (LON:TEK) portfolio company Belluscura PLC has raised US$1.33mln in a placing with a further US$268,000 coming in from a loan conversion.

Intellectual property specialist Tekcapital invested US$250,000 in the private placement and converted US$210,090 into equity to take its direct stake to about 39%.

READ: Tekcapital's augmented reality company Lucyd to close token sale next month

The placing was priced at US$0.18(13p) per share, giving Belluscura a post-money valuation of approximately US$3.7mln.

A medical equipment specialist, Belluscura had intended to float on AIM last year but was thwarted by tricky market conditions at the time.

Established in 2015, Belluscura has so far launched three products with two more in development.

READ: Tekcapital says investee company Belluscura decides not to proceed with planned AIM float

Money raised this time will go on the CURV oxygen concentrator and Snap III level of consciousness monitor.

Bob Rauker, Belluscura’s chief executive, said: “The funds will allow Belluscura to continue with its mission to provide premium, proprietary medical devices at affordable prices."

View full TEK profile View Profile

Tekcapital PLC Timeline

August 24 2018

Related Articles

The Internet of Things
September 04 2018
"We have seen double-digit revenue growth, improved gross margins from H2 2017 and our cost optimisation plan is well underway," said Yosi Fait, Telit's CEO
ai graphic
August 26 2018
The company helps commercialise innovations developed in universities around the world. The shares are trading at a 40% discount to the value of its current basket of investments
Westminster Group
April 05 2018
Westminster's pipeline of opportunities is strong in the Middle East

No investment advice

The information on this Site is of a general nature only. It does not take your specific needs or circumstances into consideration, so you should look at your own financial position, objectives and requirements and seek financial advice before making any financial decisions. You acknowledge and understand that neither the Company, its related bodies corporate, the information providers or their affiliates will advise you personally about the nature, potential value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter. You should read our FSG and any other relevant disclosure documents and if necessary seek persona advice prior to making any investment decision.

You understand and agree that no Content (as defined below) published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person.

You understand that in certain circumstances the Company, its related bodies corporate, the information providers or their affiliates may have received, or be entitled to receive, financial or other consideration in connection with promoting, and providing information about, certain entities on the Site and in communications otherwise provided to you.

You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate. From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

Before you act on any general advice we provide, please consider whether it is appropriate for your personal circumstances.

© Proactive Investors 2018

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use